Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
about
Revealing the paradox of drug reward in human evolutionEvaluation of cytochrome P450 2D6 phenotyping in healthy adult Western IndiansImplementing genotype-guided antithrombotic therapy.Association of CYP2C19*2 and *3 genetic variants with essential hypertension in KoreansCYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia.Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patientsAssociation between the N-acetylation genetic polymorphism and bronchial asthmaAllele and genotype frequency of CYP2C19 in a Tamilian population.Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks.Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factorsGenotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.Investigation of CYP2D6 Gene Polymorphisms in Turkish PopulationPolymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel.Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements.Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample.Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls.Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han ChineseCharacterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implicationsSIMULTANEOUS GENOTYPING OF CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS IN A SPANISH POPULATION THROUGH MULTIPLEX LONG POLYMERASE CHAIN REACTION AND MINISEQUENCING MULTIPLEX SINGLE BASE EXTENSION ANALYSIS
P2860
Q24646551-95960821-9F9E-4817-BCBD-ABAA72EB2B7EQ33809386-FB2DC793-0223-4D0F-A91E-531778E41BA1Q33990428-82841B29-6D1D-4AB9-8FA8-D7FD49A59D62Q34306561-E2A56CB6-C789-4752-8168-8F26E08FC068Q34552473-650B2B8E-7F29-4F64-8037-B6FBB5FFCF1AQ35549639-DE77B60C-09BA-4C6B-B598-81512B73D0E0Q35802686-AFC31F9D-7567-402D-BFC2-C0D3CDA7BE71Q35804167-AE0E58C1-BCA2-4288-B241-EEB4AE1EE2DAQ35825705-390D73EB-1531-4303-AF0F-634C41D2D626Q36053758-B619184D-CD1B-4B50-B845-B0559D2362E1Q36582619-112515B1-5B55-47DA-9852-A93EF1F4427DQ37140633-D6CE4FB0-52DD-42F1-9607-53EA88A1FCBCQ37176949-F0D8C325-FF69-4F08-86B5-B9661353DD10Q37299922-711E984C-1185-4EEB-9D91-F72DCB74116FQ37611786-07684901-4740-493F-9D50-1E5ED7F41F16Q37698407-0171FCE6-49B8-4B57-8140-FCEFF9B2FF34Q38651234-1258578F-D8E9-4ABA-B6CC-66BF9DA0B3F5Q40085185-F0DC5A60-2A8A-47F6-821D-6A548DBA4834Q41987357-7DF4E3B2-A531-47DF-AAE9-B6C2E642C897Q43071574-F8B8F0B7-538E-4472-8416-FFE7684284F8Q43097393-A18A9F6A-9C14-40EB-BAA9-BE322781AD5FQ46619481-BC4D36E3-CE2C-4AF2-B1EC-41AF57B0ABCDQ46894635-17D0F76D-A32B-4260-8A6C-48A31B3B950CQ47231767-A031B671-AA28-45FB-805C-38E7768DE9B9Q47910941-E4E5D39B-191C-4D29-BE5F-7FD97A3DAF73Q51799773-B98C11DC-4B5F-4E10-8A06-52FBB7D30CADQ57251500-02D402EA-EFC1-4BB8-BC6D-9A0E892472C4Q57585736-626F1495-15E8-474A-9404-242631D18B9EQ57602715-1F7702FE-781F-4F02-9A50-52A54729D507
P2860
Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Low frequency of defective all ...... 2D6 in the Turkish population.
@en
Low frequency of defective all ...... 2D6 in the Turkish population.
@nl
type
label
Low frequency of defective all ...... 2D6 in the Turkish population.
@en
Low frequency of defective all ...... 2D6 in the Turkish population.
@nl
prefLabel
Low frequency of defective all ...... 2D6 in the Turkish population.
@en
Low frequency of defective all ...... 2D6 in the Turkish population.
@nl
P2093
P1476
Low frequency of defective all ...... 2D6 in the Turkish population.
@en
P2093
A S Aynacioglu
J Brockmöller
S Kortunay
S O Kayaalp
T Schröder
P304
P356
10.1016/S0009-9236(99)90056-5
P407
P577
1999-08-01T00:00:00Z